Vaccine for COVID-19: Trial Begins Today in Seattle
Could take a year to 18-months to fully validate the vaccine
According to reports from the AP, a trial for a COVID-19 vaccine has begun today at the Kaiser Permanente Washington Health Research Institute in Seattle.
The trial involves 45 young, healthy volunteers who will each receive 2 vaccine injections, 28-days apart. The vaccine, co-developed by NIH and Moderna Inc., has been made by recreating a segment of this virus’ DNA in a lab.
It could take a year to 18-months before they can ‘fully validate’ the vaccine.
This is not the only vaccine in the works. Research is being done around the world.
Last week, a team of researchers from Sunnybrook Research Institute, McMaster University and University of Toronto announced that they have been able to isolate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the ongoing outbreak of COVID-19. (Read more from Barrie360)
